CRDF
Cardiff Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.09
+0.93%Margins
Gross margin
100.0%
EBITDA margin
-7665.2%
EBIT margin
-8320.1%
Net margin
-7884.1%
FCF margin
-8054.3%
-151.0%
Return on equity
-107.3%
Return on assets
-156.6%
Return on invested capital
0.01x
Asset turnover
-$40.9M
Cash from operations
$0.44
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026